SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019993
Filing Date
2023-12-22
Accepted
2023-12-22 16:05:29
Documents
13
Period of Report
2023-12-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sngx-20231221x8k.htm   iXBRL 8-K 38775
  Complete submission text file 0001558370-23-019993.txt   168385

Data Files

Seq Description Document Type Size
2 EX-101.SCH sngx-20231221.xsd EX-101.SCH 3936
3 EX-101.DEF sngx-20231221_def.xml EX-101.DEF 3497
4 EX-101.LAB sngx-20231221_lab.xml EX-101.LAB 17260
5 EX-101.PRE sngx-20231221_pre.xml EX-101.PRE 10064
7 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20231221x8k_htm.xml XML 4890
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 231509780
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)